From being declared polio-free to successfully eliminating smallpox, India has achieved significant outcomes. Similarly, India has achieved milestones in healthcare technology and is rapidly evolving. The Indian healthcare IT market is increasing, and it is expected to reach USD 96.2 billion by 2034.
However, India lags behind the U.S. in cancer survival rates. According to an American Cancer Society report published in 2026, the overall survival rate for all cancers combined was approximately 70% for people diagnosed between 2015 and 2021. The survival rate of various cancers has increased, such as:
- Multiple myeloma: from 32% to 62%.
- Liver cancer: from 7% to 22%.
- Metastatic melanoma: from 16% to 35%.
- Lung cancer: from 20% to 37%.
- Metastatic lung cancer: from 2% to 10%.
On the other hand, there is no single consolidated national 5-year survival statistic for India. But registry data for specific cancers show significantly lower survival rates than in other high-income countries.
- According to the Indian Council of Medical Research – National Centre for Disease Informatics and Research (ICMR-NCDIR) data, the 5-year relative survival rate for cervical cancer is approximately 51-52% for people diagnosed between 2012 and 2016.
- The 5-year relative survival rate for breast cancer is approximately 66% for people diagnosed between 2012 and 2015. Out of every 100 breast cancer patients, about 66 survive for five years. This data is based on 11 specific geographical areas of India, not the overall national survival rate.
There are several reasons behind these lower survival rates. Here, we understand the factors and gaps, such as detection, infrastructure, and health technology.
Survival Is Not Just About Treatment, It’s About Early Detection
The cancer survival rate is lower than that of other high-income countries, not because their treatment is better than that of India. This is not the only reason; however, an important factor is that in the U.S., patients are detected with cancer at an early stage. They regularly undergo screening tests. The detection of cancer depends mainly on the type of cancer. In most breast cancer cases, ~66-67% of the patients are detected at an early stage (localized), ~25% at the middle (regional) stage, and only ~6% at the advanced (distant) stage.
Similarly, in prostate cancer, ~70% of the patients are detected at an early stage (localized), ~14% at the middle (regional) stage, and only ~9% at the advanced (distant) stage.
In colorectal cancer, ~33% of the patients are detected at an early stage (localized), ~40% at the middle (regional) stage, and only ~20% at the advanced (distant) stage.
In Lung cancer, ~25-30% of the patients are detected at an early stage (localized), ~22-25% at the middle (regional) stage, and only ~45-50% at the advanced (distant) stage.
India has limited population health data analytics compared to the U.S. But in most cases, approximately 40-48% of patients are diagnosed with cancer in distant metastasis stages, ~50-60% are diagnosed in the advanced stage, and only ~15-33% of cases are diagnosed in the early stage. The data will vary by cancer type.
If the rate of early diagnosis increases in India, then the survival rate of cancer patients will improve.
The Technology Factor: How Digital Infrastructure Shapes Outcomes
The cancer survival rate depends not only on treatment but also on digital health infrastructure. The digitization of oncology workflows, structured screening registries, and tracking systems helps patients with early detection.
From diagnosis to treatment planning, processes can be made more efficient with reduced errors if the integration of all these systems, Hospital Information Systems (HIS), Radiology Information Systems (RIS), and Laboratory Information Systems (LIS), is seamless.
The Clinical Decision Support System (CDSS) is an intelligent tool that helps doctors by analyzing patients’ data and providing evidence-based recommendations, diagnoses, and treatment plans.
With the help of the Population Health Analytics and Management system, the government will identify the most urgent care needs and implement screening programs in these areas. These digital infrastructure systems can enable earlier cancer detection, directly improving survival rates across all cancer types.
AI in Diagnostics: Can Innovation Close the Detection Gap?
Today, artificial intelligence (AI) in diagnostics is performing at a level comparable to that of a doctor. AI analyzes CT, MRI, and mammography images to detect tumors and highlight suspicious areas. These tools identify patterns that human eyes sometimes miss.
A doctor can trust AI only if it will generate results with appropriate explanations. If AI is highlighting a suspicious area with comparison or reasoning, it will help doctors in developing clinical trust.
In India, several AI detectors have been developed. Recently, a team at IISER Bhopal introduced an AI model, ProtoRadNet, that analyzes patients’ MRI scans, diagnoses tumors, and highlights suspicious areas. Although its accuracy is 92.16%, this innovation is helpful for radiologists.
These AI tools will not replace doctors; instead, they act as support tools that assist in early detection and improve survival outcomes.
Beyond Algorithms: What India Needs to Improve Survival
AI tools and advanced machines are not enough to improve the cancer survival outcomes. Instead, a strong, integrated health-tech ecosystem is needed. Firstly, all systems, including HIS, RIS, LIMS, and oncology software, are interconnected to facilitate seamless communication. If the patient’s screening data, biopsy reports, and imaging reports are all available on an interconnected digital system, then diagnoses and treatment planning can be fast.
Breast and cervical cancers are easily detectable at an early stage, so the government should run a screening program in rural and semi-urban areas. This will lead to earlier detection and increased awareness.
Advanced treatment facilities are limited to the urban centers. Therefore, with the help of public-private technology collaboration, these advanced treatment facilities will be made available to rural and semi-urban areas. The government and private health tech innovations together develop affordable, scalable, and India-specific solutions. When infrastructure, data, and technology all work together, then only can it make realistic changes in survival rates and be sustainable.
The Road Ahead: From Data to Survival Impact
Things like replacing doctors with technologies to improve cancer survival outcomes are incorrect. Instead, they are designed to help doctors, nurses, and healthcare workers by providing detailed information and enabling timely decision-making. However, these tools work effectively only if they are integrated correctly into the clinical workflow. The most challenging part in India is awareness about the diseases, their treatment, and advanced technologies in rural areas. This could be possible with a simple digital health solution, such as tele-oncology, mobile screening units, AI-assisted imaging, and cloud-based reporting systems, which can reduce the gap. If pathology reports and scans are shared digitally with specialists from a primary health center, then early detection can be possible.
Therefore, if data are systematically collected and analyzed, policymakers and healthcare providers will be able to drive meaningful improvements in survival rates.
Reference: